Elizabeth Huzzey Headache & Migraine Management

A great resource created by migraine sufferers for migraine sufferers

Attended the Migrane Trust International Symposium in London. A great opportunity to hear from world leading experts in the headache and migraine fields, learn about up to date research and current treatments.

More useful tips and drug free options to manage your migraines.

Have a go and Test your knowledge of migraines

Although our expertise is in drug free treatment options, we do keep up to date with latest pharmaceuticals that could help headache sufferers. It is our mission to help find the most appropriate treatment approach for you.

The Milan symposium is ending with question time with the panel of international experts. Professor Coppola and Professor di Lorenzo - world leading headache neurologists; Professor Luedtke, Professor Nijs leading researchers andDean Watson. A worthwhile, high quality learning and collaborating experience.

In Milan for 4 day course/symposium on primary headaches with world leading experts and researchers. I have completed level 2 of the Watson Headache Approach taught by Dean Watson himself. An ideal opportunity to uphold the OPHM mission of education collaboration and research and improve outcome for primary headache patients.

Looking forward to being part of the team OPHM delivering a high quality and valuable course at the world leading University College of Osteopathy in London

Here is a personal account of a life with cluster headaches. Rare but correct diagnosis enables better management for sufferers.

Acupuncture for Tension type Headaches and migraine management is supported in the NICE guidelines. Elizabeth trained initially China and is a registered with the BMAS. Should you wish to explore acupuncture treatment for your headaches please contact us. We would like to help.

Last week, electroCore, LLC announced that its neuromodulation device gammaCore has received clearance from the US FDA for acute Migraine treatment in adults. The vagus nerve stimulation device was first approved by the FDA in April 2017 for the acute treatment of episodic cluster headaches.
This announcement of the new Migraine treatment marks gammaCore’s first approval for Migraine, and offers hope to people who don't get relief from other acute therapies like triptans, op...ioids and other devices.
Find out:
How does it work? How effective was it in clinical trials? Will it help other headache types? What kind of results can I expect? What side effects might I experience? When and where will it be available?
See More